2012
DOI: 10.1038/ajg.2012.38
|View full text |Cite
|
Sign up to set email alerts
|

Corrigendum: Serum and Colonic Mucosal Immune Markers in Irritable Bowel Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…So far, researches about IBS-D focused on the multiple types of immune cells that in ltrated the intestinal mucosa and released in ammatory mediators, disrupting the intestinal epithelial barrier and nervous system signaling [26]. Several studies showed that low-grade was highly associated with the pathophysiology of IBS-D [27,28]. However, the micro-level of the pathogenic mechanism of IBS-D remains doubtful because IBS-D has no structure and metabolic abnormalities accounting for its syndrome [29,30].…”
Section: Discussionmentioning
confidence: 99%
“…So far, researches about IBS-D focused on the multiple types of immune cells that in ltrated the intestinal mucosa and released in ammatory mediators, disrupting the intestinal epithelial barrier and nervous system signaling [26]. Several studies showed that low-grade was highly associated with the pathophysiology of IBS-D [27,28]. However, the micro-level of the pathogenic mechanism of IBS-D remains doubtful because IBS-D has no structure and metabolic abnormalities accounting for its syndrome [29,30].…”
Section: Discussionmentioning
confidence: 99%